Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics Shareholders Equity (Quarterly) : 274.24M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 274.24M |
| September 30, 2025 | 230.42M |
| June 30, 2025 | 204.30M |
| March 31, 2025 | 193.56M |
| December 31, 2024 | 194.04M |
| September 30, 2024 | 178.82M |
| June 30, 2024 | 132.52M |
| March 31, 2024 | 130.69M |
| December 31, 2023 | 160.17M |
| September 30, 2023 | 133.24M |
| June 30, 2023 | 111.58M |
| March 31, 2023 | 102.57M |
| December 31, 2022 | 123.05M |
| September 30, 2022 | 132.56M |
| June 30, 2022 | 173.42M |
| March 31, 2022 | 238.62M |
| December 31, 2021 | 307.37M |
| September 30, 2021 | 376.63M |
| June 30, 2021 | 213.91M |
| March 31, 2021 | 250.90M |
| December 31, 2020 | 286.38M |
| September 30, 2020 | 320.27M |
| June 30, 2020 | 360.95M |
| March 31, 2020 | 402.59M |
| December 31, 2019 | 476.42M |
| Date | Value |
|---|---|
| September 30, 2019 | 548.27M |
| June 30, 2019 | 600.06M |
| March 31, 2019 | 451.67M |
| December 31, 2018 | 342.91M |
| September 30, 2018 | 410.95M |
| June 30, 2018 | 561.90M |
| March 31, 2018 | 521.62M |
| December 31, 2017 | 352.85M |
| September 30, 2017 | 409.68M |
| June 30, 2017 | 266.89M |
| March 31, 2017 | 310.78M |
| December 31, 2016 | 360.15M |
| September 30, 2016 | 336.56M |
| June 30, 2016 | 334.24M |
| March 31, 2016 | 311.63M |
| December 31, 2015 | 347.83M |
| September 30, 2015 | 378.76M |
| June 30, 2015 | 328.90M |
| March 31, 2015 | 104.01M |
| December 31, 2014 | 122.18M |
| September 30, 2014 | 43.28M |
| June 30, 2014 | 36.31M |
| March 31, 2014 | 31.08M |
| December 31, 2013 | 45.75M |
| September 30, 2013 | 26.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 6.322B |
| Insmed, Inc. | 757.49M |
| Ligand Pharmaceuticals, Inc. | 967.52M |
| PTC Therapeutics, Inc. | -165.36M |
| Establishment Labs Holdings, Inc. | 21.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 949.87M |
| Total Liabilities (Quarterly) | 675.63M |
| Debt to Equity Ratio | 1.613 |
| Current Ratio | 2.843 |
| Net Debt Paydown Yield | 0.01% |